{
    "id": 25751,
    "fullName": "ABCB1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "ABCB1 (MDR1) over exp indicates an over expression of the Abcb1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5243,
        "geneSymbol": "ABCB1",
        "terms": [
            "ABCB1",
            "ABC20",
            "CD243",
            "CLCS",
            "GP170",
            "MDR1",
            "P-GP",
            "PGY1"
        ]
    },
    "variant": "over exp",
    "createDate": "11/17/2016",
    "updateDate": "09/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9290,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ONC201 induced apoptosis in an ABCB1 (MDR1)-over expressing myeloma cell line in culture (PMID: 26884599).",
            "molecularProfile": {
                "id": 26812,
                "profileName": "ABCB1 over exp"
            },
            "therapy": {
                "id": 1687,
                "therapyName": "ONC201",
                "synonyms": null
            },
            "indication": {
                "id": 70004,
                "name": "myeloid neoplasm",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7063,
                    "pubMedId": 26884599,
                    "title": "ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26884599"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11708,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, over expression of Abcb1 was identified as the primary mechanism of acquired Pinometostat (EPZ-5676)-resistance in leukemia cell lines harboring KMT2A-MLLT1 (MLL-ENL) fusion in culture (PMID: 28428443).",
            "molecularProfile": {
                "id": 28187,
                "profileName": "KMT2A - MLLT1 ABCB1 over exp"
            },
            "therapy": {
                "id": 2855,
                "therapyName": "Pinometostat",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9714,
                    "pubMedId": 28428443,
                    "title": "Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28428443"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11707,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, over expression of Abcb1 was identified as the primary mechanism of acquired Pinometostat (EPZ-5676)-resistance in leukemia cell lines harboring KMT2A-AFF1 (MLL-AF4) fusion in culture (PMID: 28428443).",
            "molecularProfile": {
                "id": 28188,
                "profileName": "KMT2A - AFF1 ABCB1 over exp"
            },
            "therapy": {
                "id": 2855,
                "therapyName": "Pinometostat",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9714,
                    "pubMedId": 28428443,
                    "title": "Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28428443"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11709,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, over expression of Abcb1 was identified as the primary mechanism of acquired Pinometostat (EPZ-5676)-resistance in leukemia cell lines harboring KMT2A-MLLT3 (MLL-AF9) fusion in culture (PMID: 28428443).",
            "molecularProfile": {
                "id": 28189,
                "profileName": "KMT2A - MLLT3 ABCB1 over exp"
            },
            "therapy": {
                "id": 2855,
                "therapyName": "Pinometostat",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9714,
                    "pubMedId": 28428443,
                    "title": "Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28428443"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11706,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, over expression of Abcb1 was identified as the primary mechanism of acquired Pinometostat (EPZ-5676)-resistance in leukemia cell lines harboring KMT2A (MLL) fusions in culture (PMID: 28428443).",
            "molecularProfile": {
                "id": 28190,
                "profileName": "KMT2A fusion ABCB1 over exp"
            },
            "therapy": {
                "id": 2855,
                "therapyName": "Pinometostat",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9714,
                    "pubMedId": 28428443,
                    "title": "Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28428443"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26812,
            "profileName": "ABCB1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28187,
            "profileName": "KMT2A - MLLT1 ABCB1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28188,
            "profileName": "KMT2A - AFF1 ABCB1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28189,
            "profileName": "KMT2A - MLLT3 ABCB1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28190,
            "profileName": "KMT2A fusion ABCB1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}